Abstract
More than 90% of malignant tumors arising in humans are of epithelial origin. The loss of epithelial morphology and the acquisition of mesenchymal characteristics are important early events in tumor progression. This type of morphological transformation is termed an epithelial-mesenchymal transition. These transitions occur normally during embryonic development, as well as pathologically during tumor progression. This review will encapsulate our understanding of the role that epithelial-mesenchymal transitions play during tumor progression and metastasis, and we also summarize recent results describing the roles played by such genes as E-cadherin, Snail, and TGFβ in regulating epithelial-mesenchymal transitions and metastasis.
Keywords: epithelial-mesenchymal, e-cadherin, snail, tgf
Current Genomics
Title: Epithelial-Mesenchymal Transitions and Cancer
Volume: 3 Issue: 4
Author(s): Ethan A. Carver and Thomas Gridley
Affiliation:
Keywords: epithelial-mesenchymal, e-cadherin, snail, tgf
Abstract: More than 90% of malignant tumors arising in humans are of epithelial origin. The loss of epithelial morphology and the acquisition of mesenchymal characteristics are important early events in tumor progression. This type of morphological transformation is termed an epithelial-mesenchymal transition. These transitions occur normally during embryonic development, as well as pathologically during tumor progression. This review will encapsulate our understanding of the role that epithelial-mesenchymal transitions play during tumor progression and metastasis, and we also summarize recent results describing the roles played by such genes as E-cadherin, Snail, and TGFβ in regulating epithelial-mesenchymal transitions and metastasis.
Export Options
About this article
Cite this article as:
Carver A. Ethan and Gridley Thomas, Epithelial-Mesenchymal Transitions and Cancer, Current Genomics 2002; 3 (4) . https://dx.doi.org/10.2174/1389202023350426
DOI https://dx.doi.org/10.2174/1389202023350426 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
Call for Papers in Thematic Issues
Current Genomics in Cardiovascular Research
Cardiovascular diseases are the main cause of death in the world, in recent years we have had important advances in the interaction between cardiovascular disease and genomics. In this Research Topic, we intend for researchers to present their results with a focus on basic, translational and clinical investigations associated with ...read more
Deep learning in Single Cell Analysis
The field of biology is undergoing a revolution in our ability to study individual cells at the molecular level, and to integrate data from multiple sources and modalities. This has been made possible by advances in technologies for single-cell sequencing, multi-omics profiling, spatial transcriptomics, and high-throughput imaging, as well as ...read more
New insights on Pediatric Tumors and Associated Cancer Predisposition Syndromes
Because of the broad spectrum of children cancer susceptibility, the diagnosis of cancer risk syndromes in children is rarely used in direct cancer treatment. The field of pediatric cancer genetics and genomics will only continue to expand as a result of increasing use of genetic testing tools. It's possible that ...read more
Related Journals
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Dystroglycan, A Multifunctional Adaptor Protein for Signal Transduction and A Potential Therapeutic Target
Current Signal Transduction Therapy Therapeutic Use of Vitamin D and its Analogues in Autoimmunity
Recent Patents on Inflammation & Allergy Drug Discovery Recent Patents in Circulating Cell-Free Tumor DNA as Biomarker in Cancer
Recent Patents on Biomarkers Inducible Nitric Oxide Synthase-Vascular Endothelial Growth Factor Axis: A Potential Target to Inhibit Tumor Angiogenesis by Dietary Agents
Current Cancer Drug Targets Dihidro-β-Agarofuran Sesquiterpenes: A New Class of Reversal Agents of the Multidrug Resistance Phenotype Mediated by P-Glycoprotein in the Protozoan Parasite Leishmania
Current Pharmaceutical Design From HPV Infection to Oncogenesis: A Brief Review of the Complex Immunobiological Events
Current Cancer Therapy Reviews Validated RP-HPLC Method for the Simultaneous Analysis of Gemcitabine and LY-364947 in Liposomal Formulations
Current Drug Targets EMT Blockage Strategies: Targeting Akt Dependent Mechanisms for Breast Cancer Metastatic Behaviour Modulation
Current Gene Therapy MiRNA-145 and Its Direct Downstream Targets in Digestive System Cancers: A Promising Therapeutic Target
Current Pharmaceutical Design Selection and Characterization of Human Anti-MAGE-A1 scFv and Immunotoxin
Anti-Cancer Agents in Medicinal Chemistry The Metastatic Process: Methodological Advances and Pharmacological Challenges
Current Medicinal Chemistry Chemokine Like Receptor-1 (CMKLR-1) Receptor: A Potential Therapeutic Target in Management of Chemerin Induced Type 2 Diabetes Mellitus and Cancer
Current Pharmaceutical Design Current Status and Future Perspectives of Chemoprevention in Head and Neck Cancer
Current Cancer Drug Targets The mRNA-HPV Test Utilization in the Follow Up of HPV Related Cervical Lesions
Current Pharmaceutical Design Editorial [ The Role of Epidermal Growth Factor Receptor (EGFR) Targeting Drugs in the Treatment of Cancer Guest Editor: Fortunato Ciardiello ]
Current Cancer Therapy Reviews MiRNAs in Human Cancers: The Diagnostic and Therapeutic Implications
Current Pharmaceutical Design Recent Patents on Biomarkers in Oral Cancers
Recent Patents on Biomarkers Identifying Molecular Targets Mediating the Anticancer Activity of Histone Deacetylase Inhibitors: A Work in Progress
Current Cancer Drug Targets Ribozymes in the Age of Molecular Therapeutics
Current Molecular Medicine The Genus Glycosmis [Rutaceae]: A Comprehensive Review on its Phytochemical and Pharmacological Perspectives
The Natural Products Journal